Mohamed El‐Shinawi

Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways

Sherif Ibrahim, Ramy Gadalla, Eslam A. Elghonaimy et al. · Molecular Cancer · 2017 · 277 citations · Full text

Medicine, Cancer Biology, Oncology +17

Cathepsin B: a potential prognostic marker for inflammatory breast cancer

Mohamed A. Nouh, Mona Mostafa Mohamed, Mohamed El‐Shinawi et al. · Journal of Translational Medicine · 2011 · 237 citations · Full text

Medicine, Molecular Biology, Oncology +17

International Consensus on the Clinical Management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th Anniversary Conference

Naoto T. Ueno, José Rodrigo Espinosa Fernández, Massimo Cristofanilli et al. · Journal of Cancer · 2018 · 131 citations · Full text

Medicine, Oncology, Surgery +17

Cytokines secreted by macrophages isolated from tumor microenvironment of inflammatory breast cancer patients possess chemotactic properties

Mona Mostafa Mohamed, Eslam A. Elghonaimy, Mohamed A. Nouh et al. · The International Journal of Biochemistry & Cell Biology · 2013 · 98 citations · Full text

Life Sciences, Immunology, Oncology +12

Inflammatory breast cancer: Activation of the aryl hydrocarbon receptor and its target CYP1B1 correlates closely with Wnt5a/b-β-catenin signalling, the stem cell phenotype and disease progression

Hossam Taha Mohamed, Ramy Gadalla, Noura El-Husseiny et al. · Journal of Advanced Research · 2018 · 72 citations · Full text

Medicine, Cancer Biology, Oncology +17